维普中文期刊产品整合服务
26篇 您的检索式:作者名="Maringwa"
    题名 作者 年代 出处 被引量
1Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in hmg cancer patients participating in randomized controlled trials 显示文摘Maringwa JT Quinten C King M 2011Support Care Cancer2011,19,11:1
2Minimal important differences for interpreting health-relatedquality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials显示文摘Maringwa JT Quinten C King M 2011Support Care Cancer2011,19,11:1
3Low cadmi- um exposure triggers a biphasic oxidative stress re- sponse in mice kidneys 显示文摘Thijssen S Cuypers A Maringwa J 2007Toxicology2007,236,12:1
4Minimal important differences for interpreting health-related quality of life scores from the cancer patients participating FORTC QLQ-C30 in lung in randomized controlled trials显示文摘Maringwa JT Quinten C King M 2011Support Care Cancer2011,19,17:1
5Minimal im- portant differences for nterpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer pa- tients participating in randomized controlled trials 显示文摘Maringwa J T Quinten C King M 2011Support Care Cancer2011,19,11:1
6Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials显示文摘Maringwa JT Quinten C King M 2011Support Care Cancer2011,19,11:1
7Minimal important difference-s for interpreting health-related quality of life scores from the EORTCQLQ-C30 in lung cancer patients participating in randomizedcontrolled trials显示文摘Maringwa JT QuintenC King M 2011Support Care Cancer2011,19,11:1
8Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ- c30 in lung cancer patients participating in randomized controlled trials 显示文摘Maringwa JT QuintenC King M 2011Support Care Cancer2011,19,11:1
9Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trial显示文摘Maringwa JT Quinten C King M 2011Support Care Cancer2011,19,:1
10Minimal important differ- ences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials显示文摘Maringwa JT Quinten C King M 2010Support Care Cancer2010,19,11:1
11Chronic exposure of mice to environmentally relevant,low doses of cadmium leads to early renal damage,not predicted by blood or urine cadmium levels显示文摘Thijssen S Maringwa J Faes C 0,,1:1
12Patient self-reports of symptoms and clinician ratings as predictors of overall cancer sur- vival显示文摘Quinten C Maringwa J Gotay CC 2011J Natl Cancer Instit2011,103,24:1
13Changes in expression of fibrotic markers and histopathological alterations in kidneys of mice chronically exposed to low and high Cd doses显示文摘Thijssen S Lambrichts I Maringwa J 2007Toxicology2007,238,23:1
14Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials显示文摘Maringwa JT Quinten C King M 2011Support Care Cancer2011,19,11:1
15Chronic exposure of mice to environmentally relevant, low doses of cadmium leads to early re- nal damage, not predicted by blood or urine cadmium levels 显示文摘Thijssen S Maringwa J Faes C 2007Toxicology2007,229,12:1
16Examining the rela-tionships among health - related quality - of - life indicators incancer patients participating in clinical trials: A pooled study ofbaseline EORTC QLQ - C30 data 显示文摘Martinelli F Quinten C Maringwa JT ^ al 2011Expert Rev PharmacoeconOutcomes Res2011,11,5:1
17Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials显示文摘Maringwa JT Quinten C King M 2011Support Care Cancer2011,19,11:1
18Minimal important differences for interpreting health related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials 显示文摘Maringwa JT Quinten C King M 2010Support Care Cancer2010,19,11:1
19Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials显示文摘Maringwa JT Quinten C King M 2011Support Care Cancer2011,19,11:1
20Changes in expression of fibrotic markers and histopathologieal alterations in kidneys of mice chronically exposed to low and high Cd doses 显示文摘THIJSSEN S LAMBRICHTS I MARINGWA J 2007Toxicology2007,238,23:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费